SCHEMBL6734080

SCHEMBL6734080

Cc1ccc(CN(c2ccc(Oc3ccccc3)cc2)S(=O)(=O)CC(F)(F)F)cn1

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 17/20 0.61
NR3C1 P04150 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6727818 0.91 GRM2 (0.64) GRM2
SCHEMBL6736188 0.89 GRM2 (0.78) GRM2
SCHEMBL6732751 0.88 GRM2 (0.73) GRM2NR3C1
SCHEMBL6733179 0.88 GRM2 (0.61) GRM2NR3C1
SCHEMBL6733345 0.87 GRM2 (0.56) GRM2NR3C1
SCHEMBL7419013 0.86 GRM2 (0.55) GRM2
SCHEMBL6727779 0.85 GRM2 (0.78) GRM2
SCHEMBL6738582 0.84 GRM2 (0.52) GRM2NR3C1
SCHEMBL6772754 0.83 GRM2 (0.57) GRM2
SCHEMBL5268742 0.82 GRM2 (0.62) GRM2NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006114-A1 Potentiators of glutamate receptors ELI LILLY AND COMPANY 2004-01-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006114-A1 Potentiators of glutamate receptors GRM1, GRIN1, GRM2 GRM2 3/4885NR3C1 336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.